SEBASTIAN AFONSO: Open Payments
NPI 1700360526 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,212 in 94 payments from 20 companies in 2025. Trend: 2023 $2,018 · 2024 $2,611 · 2025 $2,212
Food & beverage: $2,212
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $398 |
| GENZYME CORPORATION | 7 | $228 |
| LEO Pharma Inc. | 9 | $219 |
| UCB, Inc. | 13 | $201 |
| Regeneron Healthcare Solutions, Inc. | 9 | $198 |
| Amgen Inc. | 6 | $130 |
| PFIZER INC. | 6 | $126 |
| Lilly USA, LLC | 1 | $124 |
| Organogenesis Inc. | 2 | $73 |
| Galderma Laboratories, L.P. | 4 | $73 |
Products named: DUPIXENT, RINVOQ, Bimzelx, ADBRY, SKYRIZI, OTEZLA, CIBINQO, EBGLYSS.
Industry payments across GA — which companies pay providers there.
